Discover
INGN
Inogen, Inc.
6.65
2 x 4.76
2 x 8.26
bid
ask
+
0.20
3.10%
2 @ 04:00 PM
6.65 +0.00 (0.00%)
| Ytd | -1.04% | |
| 1y | -6.34% |
6.41
day range
6.71
5.34
52 week range
9.13
| Open | 6.46 | Prev Close | 6.45 | Low | 6.41 | High | 6.71 | Mkt Cap | 180.05M |
| Vol | 260.94K | Avg Vol | 339.95K | EPS | -0.91 | P/E | N/A | Forward P/E | -5.44 |
| Beta | 1.04 | Short Ratio | 3.36 | Inst. Own | 89.67% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 6.65 | 200-d Avg | 6.87 | 1yr Est | 10.00 |
INGN News
benzinga.com
Inogen Appoints Andy Reding As COO, Effective On July 6, 2026
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products f
businesswire.com
Inogen Announces the Appointment of Andy Reding as Chief Operating Officer
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces the Appointment of Andy
zacks.com
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
INGN's POC strength, expanding respiratory portfolio and international momentum support growth, thou